MARKET

BBC

BBC

Virtus LifeSci Biotech Clinical Trls ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

44.61
+0.43
+0.98%
Closed 16:00 11/25 EST
OPEN
44.32
PREV CLOSE
44.18
HIGH
44.72
LOW
44.32
VOLUME
6.16K
TURNOVER
--
52 WEEK HIGH
45.70
52 WEEK LOW
23.00
TOTAL ASSET
37.02M
YTD YIELD
0.44%
1D
5D
1M
3M
1Y
5Y
News
Performance
Saudi Wealth Fund Making Another Splash, This Time at Home
Bloomberg · 11/17 14:58
Traders Shorting VIX Spur Inflows to $1.2 Billion Fund Down 34%
Bloomberg · 11/17 13:04
Saudi Wealth Fund Cuts U.S. Stock Holdings, Holds On to Uber
Bloomberg · 11/17 05:21
Tesla Is So Huge It May Take Two Steps to Put It in the S&P 500
Bloomberg · 11/17 00:09
Hedge Funds Bet on Tech Ahead of Unpredictable Fourth Quarter
Bloomberg · 11/16 23:08
A $1.3 Billion Leveraged Bet Against Tech Sees Record Outflows
Bloomberg · 11/16 16:52
Cathie Wood’s Ark Invest Rocked as Shareholder Seeks Control
A fight for control has broken out at one of the biggest success stories in the exchange-traded fund world this year.
Bloomberg · 11/16 15:48
Turkey’s Currency-Battered Stocks Have Been Luring U.S. Investors
Bloomberg · 11/16 12:46
More
No Data
Learn about the latest financial forecast of BBC. Analyze the recent business situations of Virtus LifeSci Biotech Clinical Trls ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
-6.1209%
--
3-Month
-7.1870%
--
6-Month
7.6456%
--
1-Year
0.4368%
--
5-Year
4.6049%
--
Since Inception
7.9926%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
Virtus LifeSci Biotech Clinical Trls ETF
Risk
Low risk
Inception Date
2014-12-16
Benchmark
NASDAQ Composite CR
Advisor Company
Virtus
Custodian
The Bank of New York Mellon
Manager
Brown/Kadushin